Resmed ( (RMD) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ResMed shares are moving sharply as fresh survey data eases fears about competition from popular weight-loss drugs. A proprietary Stifel survey found that patients using GLP-1 treatments are largely sticking with their CPAP devices, calming worries that demand for sleep apnea equipment could erode.
The upbeat outlook has sparked a strong relief rally that is overshadowing recent negatives, including insider share sales and a small analyst downgrade earlier this week. Sentiment is getting an extra lift from news that Aquatic Capital Management has more than doubled its stake in the company, signaling renewed institutional confidence.
More about Resmed
YTD Price Performance: -3.94%
Average Trading Volume: 1,072,973
Technical Sentiment Signal: Hold
Current Market Cap: $33.63B
For further insights into RMD stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.